Key result
Bariatric surgery linked to ~63% lower depression scores at 6 months, especially with comorbid anxiety.
Why the study?
Factors influencing depressive symptoms before and after metabolic and bariatric surgery, as well as contributing factors to subgroups with distinct depression trajectories, were not well understood.
Does metabolic and bariatric surgery improve depressive symptoms in obese patients?
Observational (n=184)
No
Does metabolic and bariatric surgery improve depressive symptoms in obese patients?
Absolute Event Rate: 2.4% vs 6.4%
p-value: p=<0.001
Metabolic and bariatric surgery is associated with a significant reduction in depressive symptoms over 6 months, with distinct recovery trajectories influenced by baseline anxiety, medication adherence, and vitamin B12 levels.
MBS may alleviate depressive symptoms; hypothesis-generating and should not yet change practice without RCTs.
Background and aims This study aims to investigate the factors influencing depressive symptoms both before and after metabolic and bariatric surgery (MBS) in obese patients, as well as to analyze the contributing factors to heterogeneous subgroups with distinct depression trajectories. Methods This study enrolled 184 obese patients who underwent MBS at Changzhou Second People’s Hospital between October 2023 and October 2024. Body composition and clinical laboratory data were obtained preoperatively, as well as at 1 month, 3 months, and 6 months postoperatively. The 9-item patient health questionnaire was used to assess the severity of depressive symptoms. Results Depressive scores showed a significant decrease at 1 month, 3 months, and 6 months postoperatively. Multiple linear regression indicated that anxiety consistently served as a risk factor for the development of depression in MBS patients, while higher medication adherence, vitality, role emotional, and resting potential scores acted as protective factors against depression progression. Growth mixture model analysis identified two heterogeneous subgroups in the depression trajectories of MBS patients. Binary logistic regression revealed that patients with comorbid hypertension and low health transition scores exhibited lower preoperative depression levels and were more likely to belong to the “mild depression decline group”. In contrast, patients with comorbid anxiety, low medication adherence, and high vitamin B12 levels showed higher preoperative depression levels and tended to belong to the “significant depression decline group”. Conclusions Patients with anxiety disorder are prone to developing depression after MBS. Patients with comorbid anxiety, low medication adherence, and high vitamin B12 levels exhibit higher preoperative depression severity and require particular attention. However, their postoperative depression levels decreased significantly, highlighting the importance of postoperative follow-up for effective emotional management in this subgroup.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) conducted an observational in Obesity (n=184). Metabolic and bariatric surgery vs. Preoperative baseline was evaluated on PHQ-9 depression score (p=<0.001). Metabolic and bariatric surgery significantly reduced depressive symptoms over 6 months postoperatively, with patients having comorbid anxiety and low medication adherence showing the most significant decline.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: